Arysta LifeScience Europe announced a new organizational structure to leverage its scale and accelerate the company’s growth in this market. The new European management structure, which is effective immediately, is designed to strengthen the company’s performance while capitalizing on long-term growth opportunities, Arysta said.
“We are eager to capitalize on the unique growth opportunities that will emerge from having Arysta LifeScience, Chemtura AgroSolutions and Agriphar under one umbrella,” said Jose Nobre, Arysta LifeScience’s new Business Unit President, Europe. “Our newly created company, Arysta LifeScience, possesses a strong bias toward high-growth areas, and with an industry-leading portfolio of active ingredients and registrations, we believe we are ideally positioned to continue developing solutions that will address the evolving demands of farmers around Europe.”
The company, which isowned by Platform Specialty Products, says it can now offer customers a “more complete portfolio of traditional crop protection products, seed treatments, biological products, biostimulants, innovative nutrition and adjuvants.”
将管理欧洲业务部门的新领导团队包括：研发主管 Paul Thompson、营销主管 Jozef Michrina、商业分销国家和第三方关系主管 Guy de Froberville、中部主管 Hildo Brilleman和东欧，Gilles Cerutti 担任运营和供应链主管，Wim van de Wiele 担任首席财务官，Guilhem de Gaillard 担任股份公司法律顾问，Michel Bihry 担任人力资源主管。
“Our global footprint and strong presence in Europe, with over $450 million of sales, 14 subsidiaries and two world-class formulation and packaging sites, will give us the flexibility to meet local needs and provide our customers and business partners with growth opportunities that benefit all,” Nobre added.